Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
| 13.14 | |
| 13.11 | |
| - | |
| 13.17 | |
| 13.03 | |
| 10.13-15.26 | |
| 8 265 M | |
| 6.7385 | |
| 268 M | |
| 590 346 M | |
| 0.0475 | |
| 0.877 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
As the Hong Kong market experiences a notable upswing, buoyed by China's recent stimulus measures, investors are increasingly looking towards dividend stocks for stable returns amidst this renewed eco...
As global markets navigate a period of economic adjustments, the Hong Kong market has shown resilience amid broader fluctuations. With the European Central Bank cutting rates and anticipation of simil...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
